Skip to main content

Alvesco FDA Approval History

FDA Approved: Yes (First approved January 10, 2008)
Brand name: Alvesco
Generic name: ciclesonide
Dosage form: Inhalation Aerosol
Company: Nycomed
Treatment for: Asthma

Alvesco (ciclesonide) is an inhaled corticosteroid indicated for the maintenance treatment of asthma and as prophylactic therapy in adult and adolescent patients aged 12 years and older.

Development timeline for Alvesco

Jan 16, 2008Approval Alvesco Gains FDA Approval for the U.S. Market
Oct 26, 2004Aventis Receives Approvable Letter from U.S. Food and Drug Administration for Alvesco (ciclesonide) for Treatment of Persistent Asthma
Jan  1, 2004Aventis Submits New Drug Application to FDA for Asthma Drug Alvesco (ciclesonide)

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.